Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomas.
Bisaccia J, Meyer S, Bertrand-Chapel A, Hecquet Q, Barbet V, Kaniewski B, Léon S, Gadot N, Rochet I, Fajnorova I, Leblond P, Cordier-Bussat M, Corradini N, Vasiljevic A, Billaud M, Picard C, Broutier L, Gallerne C, Dutour A, Blay JY, Castets M. Bisaccia J, et al. Among authors: leblond p. Cell Death Discov. 2023 Jul 7;9(1):230. doi: 10.1038/s41420-023-01513-y. Cell Death Discov. 2023. PMID: 37414800 Free PMC article.
NTRK2 gene fusion and resistance mutation: Seventeen-year course of a paediatric glioma.
Barritault M, Poncet D, Meyronet D, Vasiljevic A, Lopez J, Descotes F, Mottolese C, Basle A, Benoit-Janin M, Pissaloux D, Karanian M, Bringuier PP, Leblond P. Barritault M, et al. Among authors: leblond p. Pediatr Blood Cancer. 2021 Sep;68(9):e29114. doi: 10.1002/pbc.29114. Epub 2021 May 18. Pediatr Blood Cancer. 2021. PMID: 34003575 No abstract available.
H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines.
Rakotomalala A, Bailleul Q, Savary C, Arcicasa M, Hamadou M, Huchedé P, Hochart A, Restouin A, Castellano R, Collette Y, Dieny E, Vincent A, Angrand PO, Le Bourhis X, Leblond P, Furlan A, Castets M, Pasquier E, Meignan S. Rakotomalala A, et al. Among authors: leblond p. Cancers (Basel). 2021 Nov 5;13(21):5551. doi: 10.3390/cancers13215551. Cancers (Basel). 2021. PMID: 34771714 Free PMC article.
Results of the treatment of pineal tumors in children: the Lyon experience.
Szathmari A, Beuriat PA, Vasiljevic A, Leblond P, Faure-Conter C, Claude L, Di Rocco F, Mottolese C. Szathmari A, et al. Among authors: leblond p. Childs Nerv Syst. 2023 Sep;39(9):2317-2327. doi: 10.1007/s00381-022-05649-7. Epub 2022 Oct 15. Childs Nerv Syst. 2023. PMID: 36242638
Posterior fossa ependymoma in children: A long-term single-center experience.
Boukaka RG, Szathmari A, Di Rocco F, Leblond P, Faure-Conter C, Claude L, Vasiljevic A, Beuriat PA, Mottolese C. Boukaka RG, et al. Among authors: leblond p. Neurochirurgie. 2023 Jul;69(4):101459. doi: 10.1016/j.neuchi.2023.101459. Epub 2023 Jun 7. Neurochirurgie. 2023. PMID: 37295279
Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial.
Verschuur A, Heng-Maillard MA, Dory-Lautrec P, Truillet R, Jouve E, Chastagner P, Leblond P, Aerts I, Honoré S, Entz-Werle N, Sirvent N, Gentet JC, Corradini N, André N. Verschuur A, et al. Among authors: leblond p. Front Pharmacol. 2018 Sep 27;9:00950. doi: 10.3389/fphar.2018.00950. eCollection 2018. Front Pharmacol. 2018. PMID: 30319400 Free PMC article.
254 results